In conjunction with the American Association for Pediatric Ophthalmology and Strabismus and the American Academy of Pediatrics
Date: Saturday, Nov. 14
Pediatric Ophthalmology Program
Daniel E. Neely, MD; R. Michael Siatkowski, MD
Program Planning Group
Oscar A. Cruz, MD; Sean P. Donahue, MD; Jane C. Edmond, MD; Laura B. Enyedi, MD; Daniel J. Karr, MD; Daniel E. Neely, MD; David A. Plager, MD; R. Michael Siatkowski, MD
The 2015 Pediatric Ophthalmology Subspecialty Day will promote, among practicing ophthalmologists and other eye care professionals, a better understanding of the whole patient in order to enable better treatment outcomes in pediatric patients with eye disease as well as children and adults with strabismus. It will provide participants with an understanding of newer developments in this field and an appreciation of the challenges and controversies that exist.
What Is The Professional Practice Gap That This Activity Will Address?
- Complex strabismus patients present unique challenges to treating ophthalmologists. Innovative strategies and nontraditional thinking are frequently required to successfully manage these difficult patients.
- Retinoblastoma management has changed dramatically over the last decade.
- Retinopathy of prematurity is becoming increasingly common around the world as more and more significantly preterm infants survive. Methods of evaluation and treatment of this disease are also rapidly evolving.
- Ethical medical dilemmas are particularly significant when the patient is a minor.
- Ocular motility disorders are unusual, and most practicing ophthalmologists are not comfortable with them.
The intended target audience for this program is pediatric ophthalmologists, comprehensive ophthalmologists, medical professionals, visual physiologists and orthoptists who are involved in maintaining high-quality health care for the pediatric and strabismus populations.
The goals of this program are to:
- Provide attendees with a broad-based update on the diagnosis and management of pediatric ophthalmic diseases and strabismus in adults and children.
- Provide insight into new or controversial therapeutic options for treatment of a variety of pediatric eye disorders.
This meeting will enable attendees to:
- Evaluate new disease entities, practices, technologies and treatment that may change current practice.
- Plan the surgical treatment of complex strabismus in adults and children.
- Prepare for unexpected surgical outcomes and learn how to successfully manage them when they occur.
- Understand current treatment strategies for retinoblastoma that increasingly emphasize preservation of vision.
- Assess and correctly diagnose challenging ocular motility cases through pattern recognition.
- Understand the controversy surrounding the roles of telemedicine and anti-VEGF agents in ROP management.
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this live activity for a maximum of 7 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors, spouses and guests are not eligible for CME credits.